Company / Cost of Revenue
Doximity Cost of Revenue History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$55.9M
FY2024
5-year range
$39.8M / $55.9M
FY2020-FY2024
Trend
+10.3%
vs FY2023
Sector context
#97 of 107
Health Care
What the data says
Among 107 Health Care companies, Doximity is in the top 9% for cost of revenue. Increased from $53M to $56M over the past 2 years.
Based on SEC 10-K filings.
$56M in FY2024 with a 5-year CAGR of +30.3%.
Increased from $53M to $56M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +12.0%
- 5-Year CAGR
- +30.3%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 107This company $55.9M Sector average $11.8B
▼
-99.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +30.3%, indicating consistent growth.
- In FY2024, cost of revenue increased 10.3% year-over-year.
- Ranks #97 out of 107 companies in the Health Care sector.
- Lowest cost of revenue in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $55.9M | +10.3% |
| FY2023 | $50.7M | -5.3% |
| FY2022 | $53.5M | +34.4% |
| FY2021 | $39.8M | +27.5% |
| FY2020 | $31.2M | +109.4% |
| FY2019 | $14.9M | - |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026